Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:peginterferon_alfa-2b
|
| gptkbp:approvalYear |
2001
|
| gptkbp:ATCCode |
gptkb:L03AB10
|
| gptkbp:combinationTherapy |
ribavirin
|
| gptkbp:contraindication |
autoimmune hepatitis
decompensated liver disease |
| gptkbp:eliminationHalfLife |
40 hours
|
| gptkbp:form |
solution for injection
|
| https://www.w3.org/2000/01/rdf-schema#label |
PegIntron
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:mechanismOfAction |
immunotherapy
antiviral |
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:depression
gptkb:anemia fatigue neutropenia flu-like symptoms |
| gptkbp:synonym |
pegylated interferon alfa-2b
|
| gptkbp:usedFor |
gptkb:hepatitis_C
|
| gptkbp:bfsParent |
gptkb:Schering-Plough
gptkb:peginterferon_alfa-2b gptkb:pegylated_interferon_alpha gptkb:peginterferon_alfa |
| gptkbp:bfsLayer |
7
|